Nisa Investment Advisors, LLC Viking Therapeutics, Inc. Put Options Transaction History
Nisa Investment Advisors, LLC
- $21.8 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding VKTX
# of Institutions
454Shares Held
68.3MCall Options Held
7.72MPut Options Held
3.31M-
Vanguard Group Inc Valley Forge, PA10.2MShares$244 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$145 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$90.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$77.9 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$75 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $1.84B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...